PACAP(6–38) inhibits the growth of prostate cancer cells

The effects of pituitary adenylyl cyclase activating polypeptide (PACAP) analogs on prostate cancer cell lines was investigated. 125I-PACAP-27 bound with high affinity to PC-3 cells (Kd=10 nM) to a single class of sites (Bmax=30 000/cell). By RT-PCR, a major 305 bp band was observed using cDNA derived from PC-3, LNCaP or DU-145 cells. Specific 125I-PACAP binding was inhibited with high affinity by PACAP-27, PACAP-38 and PACAP(6–38) (IC50 values of 15, 10 and 300 nM, respectively) but not by PACAP(28–38). PACAP elevated cAMP and the increase caused by PACAP-27 was reversed by PACAP(6–38). PACAP transiently increased c-fos gene expression and the increase in c-fos mRNA was reversed by PACAP(6–38). PACAP-27 stimulated colony formation in PC-3 cells, whereas PACAP(6–38) reduced colony number and size. In nude mice bearing PC-3 xenografts, PACAP(6–38) significantly slowed tumor growth. These data suggest that biologically active type 1 PACAP receptors are present on human prostate cancer cells and that prostate cancer cell growth is inhibited by PACAP(6–38).